Center for Desiese Prevention

The Centers for Disease Control and Prevention (or CDC) is an agency of the United States Department of Health and Human Services based in unincorporated DeKalb County, Georgia adjacent to the campus of Emory University and east of the city of Atlanta. It works to protect public health and the safety of people, by providing information to enhance health decisions, and promotes health through partnerships with state health departments and other organizations. The CDC focuses national attention on developing and applying disease prevention and control (especially infectious diseases), environmental health, occupational safety and health, health promotion, prevention and education activities designed to improve the health of the people of the United States.

CDC Health Protection Goals
CDC is committed to achieving true improvements in people’s health. To do so, the agency is defining specific health impact goals to prioritize and focus its work and investments and measure progress.

Healthy People in Every Stage of Life
All people, and especially those at greater risk of health disparities, will achieve their optimal lifespan with the best possible quality of health in every stage of life.

Start Strong: Increase the number of infants and toddlers that have a strong start for healthy and safe lives. (Infants and Toddlers, ages 0-3 years).

Grow Safe and Strong: Increase the number of children who grow up healthy, safe, and ready to learn. (Children, ages 4-11 years).

Achieve Healthy Independence: Increase the number of adolescents who are prepared to be healthy, safe, independent, and productive members of society. (Adolescents, ages 12-19 years).

Live a Healthy, Productive, and Satisfying Life: Increase the number of adults who are healthy and able to participate fully in life activities and enter their later years with optimum health. (Adults, ages 20-49 years).

Live Better, Longer: Increase the number of older adults who live longer, high-quality, productive, and independent lives. (Older Adults, ages 50 and over).

Healthy People in Healthy Places
The places where people live, work, learn, and play will protect and promote their health and safety, especially those at greater risk of health disparities.

Healthy Communities: Increase the number of communities that protect, and promote health and safety and prevent illness and injury in all their members.

Healthy Homes: Protect and promote health through safe and healthy home environments.

Healthy Schools: Increase the number of schools that protect and promote the health, safety and development of all students, and protect and promote the health and safety of all staff. (e.g. – healthy food vending, physical activity programs).

Healthy Workplaces: Promote and protect the health and safety of people who work by preventing workplace-related fatalities, illnesses, injuries, and personal health risks.

Healthy Healthcare Settings: Increase the number of healthcare settings that provide safe, effective, and satisfying patient care.

Healthy Institutions: Increase the number of institutions that provide safe, healthy, and equitable environments for their residents, clients or inmates.

Healthy Travel and Recreation: Ensure that environments enhance health and prevent illness and injury during travel and recreation.

People Prepared for Emerging Health Threats
People in all communities will be protected from infectious, occupational, environmental, and terrorist threats. Preparedness goals will address scenarios that include natural and intentional threats. The first round of these scenarios will encompass influenza, anthrax, plague, emerging infections, toxic chemical exposure, and radiation exposure.

Pre-Event

Increase the use and development of interventions known to prevent human illness from chemical, biological, radiological agents, and naturally occurring health threats.

Decrease the time needed to classify health events as terrorism or naturally occurring in partnership with other agencies.

Decrease the time needed to detect and report chemical, biological, radiological agents in tissue, food or environmental samples that cause threats to the public’s health.

Improve the timeliness and accuracy of communications regarding threats to the public’s health.

Event

Decrease the time to identify causes, risk factors, and appropriate interventions for those affected by threats to the public’s health.

Decrease the time needed to provide countermeasures and health guidance to those affected by threats to the public’s health.

Post-Event

Decrease the time needed to restore health services and environmental safety to pre-event levels.

Improve the long-term follow-up provided to those affected by threats to the public’s health.

Decrease the time needed to implement recommendations from after-action reports following threats to the public’s health.

Healthy People in a Healthy World
People around the world will live safer, healthier and longer lives through health promotion, health protection, and health diplomacy.

Health Promotion: Global health will improve by sharing knowledge, tools and other resources with people and partners around the world.

Health Protection: Americans at home and abroad will be protected from health threats through a transnational prevention, detection and response network.

Health Diplomacy: CDC and the United States Government will be a trusted and effective resource for health development and health protection around the globe.

CDC Structure
CDC is one of the major operating components of the Department of Health and Human Services. CDC's major organizational components respond individually in their areas of expertise and pool their resources and expertise on cross-cutting issues and specific health threats. The agency comprises these major organizational components:

Office of the Director manages and directs the activities of the Centers for Disease Control and Prevention; provides overall direction to, and coordination of, the scientific/medical programs of CDC; and provides leadership, coordination, and assessment of administrative management activities.

The CDC is under the direction of Dr. Julie Louise Gerberding, M.D., M.P.H. Dr. Gerberding has been the director of the CDC since July 2002.

Coordinating Center for Environmental Health and Injury Prevention
National Center for Environmental Health/ Agency for Toxic Substances and Disease Registry (NCEH-ATSDR) provides national leadership in preventing and controlling disease and death resulting from the interactions between people and their environment.

National Center for Injury Prevention and Control (NCIPC) prevents death and disability from non occupational injuries, including those that are unintentional and those that result from violence.

Coordinating Center for Health Information and Services
National Center for Health Statistics (NCHS) provides statistical information that guides actions and policies to improve the health of the American people.

National Center for Public Health Informatics (NCPHI) provides national leadership in the application of information technology in the pursuit of public health.

National Center for Health Marketing (NCHM) provides national leadership in health marketing science and in its application to impact public health.

Coordinating Center for Health Promotion
National Center on Birth Defects and Developmental Disabilities (NCBDDD) provides national leadership for preventing birth defects and developmental disabilities and for improving the health and wellness of people with disabilities.

National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) prevents premature death and disability from chronic diseases and promotes healthy personal behaviors.

National Office of Public Health Genomics provides national leadership in fostering understanding of human genomic discoveries and how they can be used to improve health and prevent disease.

Coordinating Center for Infectious Diseases
National Center for Infectious Diseases (NCID) prevents illness, disability, and death caused by infectious diseases in the United States and around the world.

National Immunization Program (NIP) prevents disease, disability, and death from vaccine-preventable diseases in children and adults.

National Center for HIV, STD, and TB Prevention (NCHSTP) provides national leadership in preventing and controlling human immunodeficiency virus infection, sexually transmitted diseases, and tuberculosis.

Coordinating Office for Global Health provides national leadership, coordination, and support for CDC’s global health activities in collaboration with CDC’s global health partners.

Coordinating Office for Terrorism Preparedness & Emergency Response provides strategic direction for the Agency to support terrorism preparedness and emergency response efforts.

National Institute for Occupational Safety and Health (NIOSH) ensures safety and health for all people in the workplace through research and prevention.

CDC performs many of the administrative functions for the Agency for Toxic Substances and Disease Registry (ATSDR), a sister agency of CDC, and one of eight federal public health agencies within the Department of Health and Human Services. The Director of CDC also serves as the Administrator of ATSDR.

CDC Workforce
CDC’s budget for 2006 is $8.5 billion. Today the staff numbers nearly 15,000 (including 6,000 contractors and 840 Commissioned Corps officers) in 170 occupations. Engineers, entomologists, epidemiologists, biologists, physicians, veterinarians, behaviorial scientists, nurses, laboratorians, economists, health communicators, toxicologists, chemists, computer scientists, and statisticians—to name only a few—each are dedicated to the pursuit of public health.

CDC headquarters in DeKalb County, Georgia as seen from Emory UniversityCDC is headquartered in DeKalb County, Georgia, but it has 10 other locations in the United States and Puerto Rico. Those locations include Anchorage, Alaska; Cincinnati, Ohio; Fort Collins, Colorado; Hyattsville, Maryland; Morgantown, West Virginia; Pittsburgh, Pennsylvania; Research Triangle Park, North Carolina; San Juan, Puerto Rico; Spokane, Washington; and Washington, D.C. In addition, CDC staff are located in state and local health agencies, quarantine/border health offices at ports of entry, and 45 countries around the world, from Angola to Zimbabwe.

The work force is diverse and well qualified. More than a third of CDC’s employees are members of a racial or ethnic minority group, and women account for nearly 60 percent of CDC’s workforce. Nearly 40 percent of employees have a master’s degree; 25 percent have a Ph.D.; and 10 percent have medical degrees. The average age of a CDC worker is 46.

The CDC campus in Atlanta houses facilities for the research of extremely dangerous biological agents. This setting was well represented in the Dustin Hoffman film Outbreak, although the location depicted in the film was supposed to be the United States Army Medical Research Institute of Infectious Diseases bio-research facility. The CDC labs also figure prominently in the book "The Demon in the Freezer" by Richard Preston and "Virus Hunter" by C.J. Peters, former head of the Special Pathogens Branch at the CDC.

The CDC also conducts the Behavioral Risk Factor Surveillance System, the world’s largest, on-going telephone health survey system.

CDC Timeline
CDC Timeline

CDC: Then and Now
On July 1, 1946, the Communicable Disease Center was established. Its founder was a visionary leader in public health, Dr. Joseph Mountin. The new agency, which was established the year after World War II ended, descended from the wartime agency, Malaria Control in War Areas. Established as a small branch of the U.S. Public Health Service, the CDC was located on the sixth floor of the Volunteer Building on Peachtree Street in Atlanta, Georgia, hundreds of miles from Washington, D.C., and other federal agencies. The organization took root deep in the South, once the heart of the malaria zone.

CDC initially focused on fighting malaria by killing mosquitoes. In fact, malaria was by far CDC’s most absorbing interest; during the first year of operations, 59 percent of its personnel were engaged in this effort. Among its 369 employees, the key jobs at CDC were originally entomology and engineering. In 1946, there were only seven medical officers on duty.

Back then, CDC’s budget was about $1 million. The insecticide DDT, available since 1943, was the primary weapon in the malaria fight, and CDC’s early challenges included obtaining enough trucks, sprayers, and shovels to wage the war on mosquitoes. In CDC’s initial years, more than six and a half million homes were sprayed, and an early organization chart was even drawn—somewhat fancifully—in the shape of a mosquito.

But CDC was soon to spread its wings. CDC founder Dr. Joseph Mountin continued to advocate for public health issues and to push for CDC to extend its responsibilities to many other communicable diseases. In 1947, CDC made a token payment of $10 to Emory University for 15 acres of land on Clifton Road in Atlanta, the home of CDC headquarters today. CDC employees collected the money to make the purchase. The benefactor behind the “gift” was Robert Woodruff, Chairman of the Board of the Coca-Cola Company. Woodruff had a long-time interest in malaria control; it had been a problem in areas where he went hunting. As you can see, malaria was the catalyst for the agency’s creation. The scene was now set for CDC to expand its home, its mission, and its reach.

Today, CDC is the nation's premier health promotion, prevention, and preparedness agency and a global leader in public health. During the past 60 years, its name has changed to reflect its more complex mission. While it’s still known by the initials CDC, the agency’s name today is Centers for Disease Control and Prevention.

In the six decades since its founding, CDC has grown dramatically: in staff, budget and mission. The world authority on communicable disease, CDC has broadened its focus to include chronic diseases, disabilities, injury control, workplace hazards, environmental health threats, and terrorism preparedness. Whereas malaria was once considered a threat to the country’s security, new threats have now emerged. CDC tackles emerging diseases and other health risks, including birth defects, West Nile virus, obesity, avian and pandemic flu, E. coli, auto wrecks, and bioterrorism, to name a few.

CDC remains committed to its vision of healthy people in a healthy world. Part of the Department of Health and Human Services, CDC applies research and findings to improve people’s daily lives and responds to health emergencies, and in 60 years, CDC has grown in size and stature, scope and science, and reputation and reach. Memories have been built and milestones achieved. World-class scientists work in world-class facilities. But while much has changed since 1946, the heart of CDC is still its people—dedicated and diligent, persevering and professional, making a difference in lives around the world.

The CDC is one of the few Bio-Safety Level 4 laboratories in the country, as well as one of only two "official" repositories of smallpox in the world. The second smallpox stores reside at the State Research Center of Virology and Biotechnology VECTOR in the Russian Federation, though it is possible that other countries may have obtained samples during the collapse of the Soviet Union.

Center for Desiese Prevention

Amphetamine Long Term Physiological

Amphetamine or Amfetamine (Alpha-Methyl-PHenEThylAMINE), also known as, beta-phenyl-isopropylamine, and benzedrine, is a prescription stimulant commonly used to treat Attention-deficit hyperactivity disorder (ADHD) in adults and children. It is also used to treat symptoms of traumatic brain injury and the daytime drowsiness symptoms of narcolepsy and chronic fatigue syndrome. Initially it was more popularly used to diminish the appetite and to control weight. Brand names of the drugs that contain Amphetamine include Adderall, and Dexedrine. The drug is also used illegally as a recreational club drug and as a performance enhancer. The term "Amphetamine" may also refer to the class of compounds derived from Amphetamine, often referred to as the Substituted Amphetamines.

History
Amphetamine was first synthesized in 1887 by Lazar Edeleanu at the University of Berlin. He called the compound "phenylisopropylamine". It was one of a series of compounds related to the plant derivative Ephedrine, which had been purified two years previously by Nagayoshi Nagai. No pharmacological use was found for amphetamine until 1927, when pioneer psychopharmacologist Gordon Alles resynthesized it. Alles was part of a group of researchers looking for an ephedrine substitute. It was then introduced in most of the world in the form of the pharmaceutical Benzedrine. This drug was used by the militaries of several nations, especially the air forces, to fight fatigue and increase alertness among servicemen. After decades of reported abuse, the FDA banned Benzedrine inhalers, and limited amphetamines to prescription use in 1959, but illegal use became common.

The related compound methamphetamine was first synthesized from ephedrine in Japan in 1893 by chemist Nagayoshi Nagai. In 1919, crystallized methamphetamine was synthesized by Akira Ogata via reduction of ephedrine using red phosphorus and iodine. The German military was notorious for their use of methamphetamine in World War Two. The German pharmaceutical Pervitin is an oral pill of 3mg which became available in 1938, by mid-1941 it became a controlled substance because of the amount of time needed for a soldier to rest and recover after use. Military doctors were then given guidelines on how they should issue it.

In 1997 and 1998, researchers at Texas A&M University reported finding amphetamine and methamphetamine in the foliage of two Acacia species native to Texas, A. berlandieri and A. rigidula. Previously, both of these compounds had been thought to be human inventions.

Chemistry
Amphetamine is a chiral compound. The racemic mixture can be divided into its optical antipodes: levo- and dextro-amphetamine. Amphetamine is the parent compound of its own structural class, comprising a broad range of psychoactive derivatives, e.g., MDMA (Ecstasy) and the N-methylated form, methamphetamine. Amphetamine is a homologue of phenethylamine.

Traditionally the medical drug came in the racemic salt d, l-amphetamine sulfate (racemic amphetamine contains levo- and dextro-form in equal amounts). Today, dextroamphetamine sulphate is the predominant form of the drug used;[citation needed] it consists entirely of the d-isomer. Attention disorders are often treated using Adderall or a generic equivalent, a formulation of mixed amphetamine salts that contain both d/l-amphetamine and d-amphetamine in the sulfate and saccharate forms mixed to a final ratio of 3 parts d-amphetamine to 1 part l-amphetamine.

Pharmacology
Amphetamine, both as d-amphetamine (dextroamphetamine) and l-amphetamine (or a racemic mixture of the two isomers), is believed to exert its effects by binding to the monoamine transporters and increasing extracellular levels of the biogenic amines dopamine, norepinephrine (noradrenaline) and serotonin. It is hypothesized that d-amphetamine acts primarily on the dopaminergic systems, while l-amphetamine is comparatively norepinephrinergic. The primary reinforcing and behavioral-stimulant effects of amphetamine, however, are linked to enhanced dopaminergic activity, primarily in the mesolimbic DA system.

Amphetamine and other amphetamine type stimulants principally act to release dopamine into the synaptic cleft. Amphetamine has been shown to both diffuse through the intracellular membrane and travel via the DopAmine Transporter (DAT) to increase concentrations of amphetamine in the neuronal terminal. The increased amphetamine concentration releases endogenous stores of dopamine from Vesicular Monoamine Transporters (VMATs), thereby increasing intra-neuronal concentrations of transmitter. This increase in concentration effectively reverses transport of dopamine via the (DAT) into the synapse In addition, amphetamine binds reversibly to the dopamine transporter (DAT) and blocks the transporter's ability to clear DA from the synaptic space. Amphetamine also acts in this way with norepinephrine (noradrenaline) and to a lesser extent serotonin.

Research published in the Journal of Pharmacology And Experimental Therapeutics (2007), indicates that amphetamine binds to a group of receptors called TrAce Amine Receptors (TAAR). TAAR are a newly discovered receptor system which seems to be affected by a range of amphetamine-like substances called trace amines.

Medicinal use
Indicated for:
Diet suppressant
ADD
ADHD
Narcolepsy
Treatment-resistant depression

Recreational uses:
Stimulant popular with British subcultures, such as the mods,punks and goths since late 1950s

Other uses:
Used by the U.S. military to combat fatigue and increase wakefulness

Contraindications:
CNS Stimulants
MAOI use

Side effects:
Dizziness
Decrease in appetite/weight loss
Euphoria
Insomnia
Aggressiveness

Cardiovascular:
Vasoconstriction
Tachycardia

Ear, nose, and throat:
Decongestant

Eye:
Mydriasis
Relaxation of Ciliary muscle

Gastrointestinal:
Decreased Secretions
Decreased Peristalsis

Neuropharmacology:
Indirect Dopamine Agonist
Indirect Norepinephrine Agonist
Indirect Serotonin Agonist(lesser)
MAOI

Respiratory:
Bronchodilation

Along with methylphenidate (Ritalin, Concerta, etc.), amphetamine is one of the standard treatments for ADHD. Beneficial effects for ADHD can include improved impulse control, improved concentration, decreased sensory overstimulation, and decreased irritability. These effects can be dramatic, particularly in young children. The ADHD medication Adderall is composed of four different amphetamine salts, and Adderall XR is a timed release formulation of these same salt forms.

When used within the recommended doses, side-effects like loss of appetite tend to decrease over time. However, amphetamines last longer in the body than methylphenidate (Ritalin, Concerta, etc.), and tend to have stronger side-effects on appetite and sleep.

Amphetamines are also a standard treatment for narcolepsy as well as other sleeping disorders. They are generally effective over long periods of time without producing addiction or physical dependence.

Amphetamines are sometimes used to augment anti-depressant therapy in treatment-resistant depression.

Medical use for weight loss is still approved in some countries, but is regarded as obsolete and dangerous in others.

Effects of use
Amphetamines release stores of norepinephrine and dopamine from nerve endings by converting the respective molecular transporters into open channels. Amphetamine also releases stores of serotonin from synaptic vesicles when taken in relatively high doses. This effect is more pronounced in methamphetamine use. Like methylphenidate (Ritalin), amphetamines also prevent the monoamine transporters for dopamine and norepinephrine from recycling them (called reuptake inhibition), which leads to increased amounts of dopamine and norepinephrine in synaptic clefts.

These combined effects rapidly increase the concentrations of the respective neurotransmitters in the synaptic cleft, which promotes nerve impulse transmission in neurons that have those receptors.

Physical effects
Short-term physiological effects vary greatly, depending on dosage used and the method in which the drug is taken. At therapeutic levels these effects could include decreased appetite, increased stamina and physical energy, increased sexual drive/response and in some cases bruxism (teeth grinding). When the drug is abused effects could include involuntary bodily movements, hyperhidrosis, hyperactivity, jitteriness, nausea, itchy, blotchy or greasy skin, tachycardia, irregular heart rate, hypertension, and headaches. Fatigue can often follow the dose's period of effectiveness. Overdose can be treated with chlorpromazine.

Long-term abuse or overdose effects can include tremor, restlessness, changed sleep patterns, anxiety and increase in pre-existing anxiety, poor skin condition, hyperreflexia, tachypnea, gastrointestinal narrowing, and weakened immune system. Fatigue and depression can follow the excitement stage. Erectile dysfunction, heart problems, stroke, and liver, kidney and lung damage can result from prolonged abuse. When insufflated, amphetamine can lead to a deterioration of the lining of the nostrils.

Psychological effects
Short-term psychological effects of the drug at therapeutic levels could include alertness, euphoria, increased concentration, rapid talking, increased confidence, and increased social responsiveness. Effects of the drug when abused could include, nystagmus (eye wiggles), hallucinations, and loss of REM sleep the night after use.
Long-term amphetamine abuse can induce psychological effects that include insomnia, mental states resembling schizophrenia, aggressiveness (not associated with schizophrenia), addiction or dependence with accompanying withdrawal symptoms, irritability, confusion, and panic. Chronic and/or extensively-continuous use can lead to amphetamine psychosis, which causes delusions and paranoia, but this is uncommon when taken as prescribed. The abuse of an amphetamine is highly-psychologically addictive, and, with chronic abuse, tolerance develops very quickly. Withdrawal, although not physiologically threatening, is an unpleasant experience (including paranoia, depression, difficult breathing, dysphoria, gastric fluctuations and/or pain, and lethargia). This commonly leads chronic users to re-dose amphetamine frequently, explaining tolerance and increasing the possibility of addiction.

Addiction
Tolerance is developed rapidly in amphetamine abuse, therefore increasing the amount of the drug that is needed to satisfy the addiction. Many abusers will repeat the amphetamine cycle by taking more of the drug during the withdrawal. This leads to a very dangerous cycle and may involve the use of other drugs to get over the withdrawal process. Chronic abusers of amphetamines typically snort or resort to drug injection to experience the full effects of the drug in a faster and more intense way, with the added risks of infection, vein damage and higher risk of overdose. While continuous dosing with amphetamine causes tolerance, intermittent use can produce "reverse tolerance" or sensitization to some psychological effects. As a result, regular use commonly results in a quick decrease of unwanted side effects, but without an equivalent loss of its stimulant properties. Notably, the sensitization is induced more quickly, and persists far longer than withdrawal-related effects, suggesting a phenomenon more complex than a simple tolerance-induced withdrawal syndrome.

Because of the abuse of amphetamines in the U.S., most brands were discontinued by the 90's including the highly abused brand names such as Biphetamine (known as black beauties), and Preludin known on the street as Bams, which the coating was peeled and then injected. Only a few brands of amphetamines are still produced in the United States which are prescribed for narcolepsy, hyperactivity in children, or for extremely obese people.

Harm reduction approach to amphetamine use
Proponents of the harm reduction philosophy seek to minimize the harms that arise from the recreational use of amphetamines. Safer means of taking the drug—smoked, nasal, oral, and rectal—are encouraged due to the lower risk of overdose, infection, and contraction of bloodborne viruses associated with drug injection. Smoking drugs reveals their effects roughly as fast as injection, as blood directly picks up the drug at the lungs. Amphetamine, in contrast to methamphetamine, isn't smokable.

Where the strength of the drug is unknown, users are encouraged to try a small amount first to gauge the strength, to minimize the risks of overdose. For the same reason the use of two or more drugs at the one time is discouraged. Users are also discouraged from using amphetamines by themselves, as friends can assist in the event of an overdose or amphetamine psychosis.

Amphetamine users who choose to inject should always use new needles and syringes where possible, and not share these with other users. Governments that support a harm reduction approach often supply new needles and syringes on a confidential basis, as well as education on proper filtering prior to injection, safer injection techniques, and safe disposal of used injecting gear.

Amphetamine Long Term Physiological

What Are The Early Signs of Adenoma

An adenoma is a collection of growths (-oma) of glandular origin. Adenomas can grow from many organs including the colon, adrenal, pituitary, thyroid, etc. These growths are benign, although over time they may progress to become malignant (at which point they are called adenocarcinomas). Though adenomas are benign, they can cause serious health complications by compressing other structures (mass effect) and by producing large amounts of hormones in an unregulated manner (paraneoplastic syndrome).

Histopathology
Adenoma is a benign epithelial tumor arising in epithelium of mucosa (stomach, small intestine and bowel), glands (endocrine and exocrine) and ducts. In hollow organs (digestive tract) the adenoma grows upwards into the lumen - adenomatous Polyp (medicine)polyp or polypoid adenoma. Depending on the type of the insertion base, adenoma may be pedunculated lobular head with a long slender stalk, covered by normal mucosa or sessile (broad base).

The adenomatous proliferation is characterized by different degrees of cell dysplasia (atypia or loss of normal differentiation of epithelium) irregular cells with hyperchromatic nuclei, (pseudo)stratified nuclei, nucleolus, decreased mucosecretion and mitosis. The architecture may be tubular, villous or tubulo-villous. Basement membrane and muscularis mucosae are intact.

Locations

Colon
Adenomas of the colon are quite prevalent. They are found commonly at colonoscopy. They are removed because of their tendency to become malignant and lead to colon cancer.

Renal
This is a tumor which is most often small and asymptomatic and its derived from renal tubules. It may be a precursor lesion to renal carcinoma.

Adrenal
Adrenal adenomas are common, 1 in 10 people have them benign and asymptomatic. They are often found on of the abdomen, usually not as the focus of investigation; they are usually incidental findings. About one in 10,000 is malignant. Thus, a biopsy is rarely called for, especially if the lesion is homogeneous and smaller than 3 centimeters. Follow-up images in three to six months can confirm the stability of the growth.

While some adrenal adenomas do not secrete hormones at all , often some secrete cortisol causing Cushing's syndrome, aldosterone causing Conn's syndrome or androgens causing hyperandrogenism.

Thyroid
About one in 10 people are found to have solitary thyroid nodules. Investigation is required because a small percentage of these are malignant. Biopsy usually confirms the growth to be an adenoma, but sometimes, excision at surgery is required, especially when the cells found at biopsy are of the follicular type.

Pituitary
Pituitary adenomas are commonly seen in 10% of the neurological patients. A lot of them remain undiagnosed. Treatment is usually surgical, to which patients generally respond well. The most common subtype, prolactinoma, is seen more often in women, and is frequently diagnosed during pregnancy as the hormone progesterone increases its growth. Medical therapy bromocriptine generally suppresses prolactinomas; progesterone antagonist therapy has not proven to be successful.

Liver
Hepatocellular adenoma, Hepatic adenomas are a rare benign tumour of the liver, which may present with hepatomegaly or other symptoms.

Breast
Breast adenomas are called fibroadenomas. They are often very small and difficult to detect. Often there are no symptoms. Treatments can include a needle biopsy, and/or removal.

Appendix
Adenomas can also appear in the appendix. The condition is extremely rare and most physicians will never encounter an actual case, but they do happen. The most common version is called cystadenoma. They are usually discovered in the course of examination of the tissue following an appendectomy. If the appendix has ruptured and a tumor is present this presents challenges, especially if malignant cells have formed and thus spread to the abdomen. Former Vice President Dan Quayle was recently found to have cystadenoma in the appendix.

What Are The Early Signs of Adenoma